Oncomine Comprehensive Assay Plus on the Genexus Integrated Sequencer - Start-to-finish bioinformatics analysis

Summary

March 18, 2026

The Oncomine Comprehensive Assay Plus, available on the Ion Torrent Genexus System, offers a complete, end-to-end comprehensive genomic profiling (CGP) solution. The assay detects a range of genomic alterations from 517 genes, including insertions and deletions(indels), single nucleotide variants (SNVs), copy number variations (CNVs), and fusions. Additionally, the assay detects genomic signatures such as homologous recombination deficiency (HRD), tumor mutational burden (TMB), and microsatellite instability (MSI). The presentation will cover the comprehensive design of the OCA Plus, the details of the underlying bioinformatics analysis that produces each genomic endpoint, and ease of implementation into your test offering to ultimately produce a report with the associated labels, guidelines, and clinical trials associated with the detected biomarkers.

This broadcast is part of the Association for Molecular Pathology’s "Online Corporate Workshop” series.